1. OC.01.5: Follistatin-Like Protein 1 Sustains Colon Cancer Cell Growth and Survival. (15th March 2017) Authors: Bevivino, G.; De Simone, V.; Izzo, R.; Di Giovangiulio, M.; Sedda, S.; Rossi, P.; Colantoni, A.; Ortenzi, A.; Stolfi, C.; Monteleone, G. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC.03.1 REGULATION OF COLON CARCINOGENESIS BY THE ANTI-HELMINTH AGENT RAFOXANIDE. (25th March 2019) Authors: Laudisi, F.; Cherubini, F.; De Simone, V.; Di Grazia, A.; Franzè, E.; Di Fusco, D.; Dinallo, V.; Monteleone, G.; Stolfi, C. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC.06.5 GATA6 DEFICIENCY LEADS TO EPITHELIAL BARRIER DYSFUNCTION AND ENHANCES SUSCEPTIBILITY TO GUT INFLAMMATION. (September 2021) Authors: Laudisi, F.; Stolfi, C.; Bevivino, G.; Maresca, C.; Franzè, E.; Troncone, E.; Lolli, E.; Marafini, I.; Pietrucci, D.; Teofani, A.; Di Grazia, A.; Di Fusco, D.; Colantoni, A.; Ortenzi, A.; Desideri, A.; Monteleone, I.; Monteleone, G. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC.06.5 HIGH SMAD7 MARKS INFLAMMATION IN PATIENTS WITH CHRONIC POUCHITIS. (March 2023) Authors: Maresca, C.; Colella, M.; Laudisi, F.; Di Fusco, D.; Franzé, E.; Di Grazia, A.; Pacifico, T.; Lolli, E.; Zorzi, F.; Salvatori, S.; Stolfi, C.; Monteleone, I.; Monteleone, G. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC.06.6 HEPCIDIN UPREGULATION IN COLORECTAL CANCER ASSOCIATES WITH ACCUMULATION OF REGULATORY MACROPHAGES AND EPITHELIAL–MESENCHYMAL TRANSITION AND CORRELATES WITH PROGRESSION OF THE DISEASE. (March 2023) Authors: Di, Grazia A.; Di, Fusco D.; Laudisi, F.; Colella, M.; Formica, V.; Maresca, C.; Franze, E.; Pacifico, T.; Salvatori, S.; Troncone, E.; Stolfi, C.; Monteleone, I.; Monteleone, G. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC.07.4 RAFOXANIDE INDUCES IMMUNOGENIC DEATH OF COLORECTAL CANCER CELLS. (September 2021) Authors: Di Grazia, A.; Laudisi, F.; Di Fusco, D.; Franzè, E.; Ortenzi, A.; Monteleone, I.; Monteleone, G.; Stolfi, C. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.10.1 DIFFERENT CLINICAL EFFICACY OF MONGERSEN BATCHES RELATES WITH DISTINCT CHEMICAL AND PHARMACOLOGICAL PROPERTIES. (May 2022) Authors: Stolfi, C.; Marafini, I.; Arrico, L.; Demartis, S.; Bellinvia, S.; Viti, F.; Mcnulty, M.; Cabani, I.; Falezza, A.; Di Bari, L.; Monteleone, G. Journal: Digestive and liver disease Issue: Volume 54(2022)Supplement 2 Page Start: S92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC.11.1 A NOVEL GENETIC VARIANT OF SMAD7 IS ASSOCIATED WITH CROHN'S DISEASE AND DOES NOT AFFECT THE EFFICACY OF SMAD7 ANTISENSE OLIGONUCLEOTIDE. (1st October 2020) Authors: Di Fusco, D.; Marafini, I.; Stolfi, C.; Dinallo, V.; Laudisi, F.; Troncone, E.; Giuffrida, P.; Caprioli, F.; Ciccacci, C.; Borgiani, P.; Antonio, D.S.; Monteleone, I.; Monteleone, G. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC.11.2 RAFOXANIDE INHIBITS EPITHELIAL STAT3 ACTIVATION AND STAT3-DRIVEN ONCOGENIC IMMUNE RESPONSE IN THE COLORECTAL CANCER MICROENVIRONMENT. (March 2023) Authors: Pacifico, T.; Laudisi, F.; Franze, E.; Maresca, C.; Luiz-Ferreira, A.; Tomassini, L.; Ortenzi, A.; Colantoni, A.; Sica, G.S.; Monteleone, I.; Monteleone, G.; Stolfi, C. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC.11.3 THE DEUBIQUITINASE OTUD5 ENHANCES INFLAMMATORY CYTOKINE PRODUCTION IN THE GUT OF INFLAMMATORY BOWEL DISEASE PATIENTS. (1st October 2020) Authors: Dinallo, V.; Marafini, I.; Laudisi, F.; Di Fusco, D.; Troncone, E.; Franzè, E.; Stolfi, C.; Monteleone, I.; Monteleone, G. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗